Literature DB >> 15006340

Operative treatment of osteochondral lesions of the talar dome: current concepts review.

Sandro Giannini1, Francesca Vannini.   

Abstract

Osteochondral lesions of the talar dome are common problems encountered in orthopaedics. Procedures for the treatment of osteochondral lesions of the talus, including debridement of the joint, shaving of fibrillated cartilage, and resection or perforation of subchondral bone in the last decade, have been performed arthroscopically with very low morbidity. These seem to be inadequate in lesions larger than 1.5 cm(2) and have not been histologically effective in restoring the hyaline cartilage sheath. Osteochondral allografts or autogenous grafts and autologous chondrocyte transplantation have proven to be capable of restoring the articular hyaline cartilage surface, including defects larger than 2 cm(2), although with higher costs and morbidity. In this review, the aforementioned methods of operative treatment are examined and issues that are related to these methods are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15006340     DOI: 10.1177/107110070402500311

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  38 in total

1.  Arthroscopic autologous chondrocyte implantation in the ankle joint.

Authors:  Sandro Giannini; Roberto Buda; Alberto Ruffilli; Marco Cavallo; Gherardo Pagliazzi; Maria Chiara Bulzamini; Giovanna Desando; Deianira Luciani; Francesca Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-01       Impact factor: 4.342

2.  Ankle Arthroscopy With Microfracture for Osteochondral Defects of the Talus.

Authors:  Suman Medda; Ian M Al'Khafaji; Aaron T Scott
Journal:  Arthrosc Tech       Date:  2017-02-06

3.  Regenerative treatment in osteochondral lesions of the talus: autologous chondrocyte implantation versus one-step bone marrow derived cells transplantation.

Authors:  Roberto Buda; Francesca Vannini; Francesco Castagnini; Marco Cavallo; Alberto Ruffilli; Laura Ramponi; Gherardo Pagliazzi; Sandro Giannini
Journal:  Int Orthop       Date:  2015-02-08       Impact factor: 3.075

4.  Comparison of clinical outcomes between arthroscopic subchondral drilling and microfracture for osteochondral lesions of the talus.

Authors:  Jun-Ik Choi; Keun-Bae Lee
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-02-04       Impact factor: 4.342

5.  T2-mapping at 3 T after microfracture in the treatment of osteochondral defects of the talus at an average follow-up of 8 years.

Authors:  Christoph Becher; David Zühlke; Christian Plaas; Marc Ewig; Tilman Calliess; Christina Stukenborg-Colsman; Hajo Thermann
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-02-23       Impact factor: 4.342

6.  Critical three-dimensional factors affecting outcome in osteochondral lesion of the talus.

Authors:  Chayanin Angthong; Ichiro Yoshimura; Kazuki Kanazawa; Akinori Takeyama; Tomonobu Hagio; Takahiro Ida; Masatoshi Naito
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-01-18       Impact factor: 4.342

7.  Potential pitfall in the microfracturing technique during the arthroscopic treatment of an osteochondral lesion.

Authors:  Christiaan J A van Bergen; Peter A J de Leeuw; C Niek van Dijk
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2008-09-23       Impact factor: 4.342

8.  Arthroscopic microfracture for osteochondral lesions of the talus.

Authors:  Keun-Bae Lee; Long-Bin Bai; Jae-Yoon Chung; Jong-Keun Seon
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-09-25       Impact factor: 4.342

9.  One-step bone marrow-derived cell transplantation in talar osteochondral lesions.

Authors:  Sandro Giannini; Roberto Buda; Francesca Vannini; Marco Cavallo; Brunella Grigolo
Journal:  Clin Orthop Relat Res       Date:  2009-05-16       Impact factor: 4.176

10.  [Microfracture technique for the treatment of articular cartilage lesions of the talus].

Authors:  C Becher; A Driessen; H Thermann
Journal:  Orthopade       Date:  2008-03       Impact factor: 1.087

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.